O'Meara A - Search Results

1

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.

Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman F, London WB, McGrady PW, Higgins DG, O'Meara A, O'Sullivan M, Stallings RL. Bray I, et al. PLoS One. 2009 Nov 16;4(11):e7850. doi: 10.1371/journal.pone.0007850. PLoS One. 2009. PMID: 19924232 Free PMC article.

2

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.

Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, Buckley PG, Ryan J, O'Meara A, O'Sullivan M, Stallings RL. Foley NH, et al. Mol Cancer. 2010 Apr 21;9:83. doi: 10.1186/1476-4598-9-83. Mol Cancer. 2010. PMID: 20409325 Free PMC article.

3

Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?

Stallings RL, Howard J, Dunlop A, Mullarkey M, McDermott M, Breatnach F, O'Meara A. Stallings RL, et al. Cancer Genet Cytogenet. 2003 Jan 15;140(2):133-7. doi: 10.1016/s0165-4608(02)00681-7. Cancer Genet Cytogenet. 2003. PMID: 12645651

4

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, Catchpoole D, Culhane AC, Jeffery I, Gallagher WM, Stallings RL. McArdle L, et al. Carcinogenesis. 2004 Sep;25(9):1599-609. doi: 10.1093/carcin/bgh173. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090470 Review.

5

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.

Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, Davidoff AM, Stallings RL. Ryan J, et al. Br J Cancer. 2012 Sep 4;107(6):967-76. doi: 10.1038/bjc.2012.356. Epub 2012 Aug 14. Br J Cancer. 2012. PMID: 22892391 Free PMC article.

6

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.

Stallings RL, Nair P, Maris JM, Catchpoole D, McDermott M, O'Meara A, Breatnach F. Stallings RL, et al. Cancer Res. 2006 Apr 1;66(7):3673-80. doi: 10.1158/0008-5472.CAN-05-4154. Cancer Res. 2006. PMID: 16585193

7

Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization.

Breen CJ, O'Meara A, McDermott M, Mullarkey M, Stallings RL. Breen CJ, et al. Cancer Genet Cytogenet. 2000 Jul 1;120(1):44-9. doi: 10.1016/s0165-4608(99)00252-6. Cancer Genet Cytogenet. 2000. PMID: 10913676

8

Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma.

Mullarkey M, Breen CJ, McDermott M, O'Meara A, Stallings RL. Mullarkey M, et al. Cytogenet Cell Genet. 2001;95(1-2):9-11. doi: 10.1159/000057009. Cytogenet Cell Genet. 2001. PMID: 11978962

9

Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F. Stallings RL, et al. Cytogenet Genome Res. 2004;106(1):49-54. doi: 10.1159/000078560. Cytogenet Genome Res. 2004. PMID: 15218241

10

Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, Breatnach F, O'Meara A. Stallings RL, et al. Cancer Genet Cytogenet. 2004 Oct 1;154(1):44-51. doi: 10.1016/j.cancergencyto.2004.04.003. Cancer Genet Cytogenet. 2004. PMID: 15381371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters